Cognition Therapeutics Receives European Patent Covering its Alzheimer’s Disease Candidate, Elayta™ Globenewswire By John Harbison|2019-02-26T15:09:04-08:00February 21, 2019|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Cognition Therapeutics Receives European Patent Covering its Alzheimer’s Disease Candidate, Elayta™ Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
